TARPLIN, DOWNS & YOUNG, LLC

Lobbying for ASTRAZENECA

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Budget/Appropriations

federal budget issues

Medicare/Medicaid

Medicare and Medicaid drug and coverage issues, orphan drugs

Health Issues

IRA, drug pricing in federal programs, orphan drug issues, oncology, transparency

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.